Erasca Ownership

Who are the major shareholders and have insiders been buying or selling?

Recent Insider Transactions

NasdaqGS:ERAS Recent Insider Transactions by Companies or Individuals
Date	Value	Name	Entity	Shares	Max Price
21 May 24	BuyUS$181,920	Alexander Casdin	Individual	80,000	US$2.27
06 Dec 23	BuyUS$1,696,179	Jonathan Lim	Individual	1,000,000	US$1.72
06 Dec 23	BuyUS$18,480	Valerie Harding-Start	Individual	10,000	US$1.85
06 Dec 23	SellUS$18,349,577	Cormorant Asset Management, LP	Company	10,813,246	US$2.01
04 Dec 23	BuyUS$49,785	Alexander Casdin	Individual	30,000	US$1.66

Insider Trading Volume

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.

Ownership Breakdown

What is the ownership structure of ERAS?
Owner Type	Number of Shares	Ownership Percentage
General Public	16,331,504	5.78%
Individual Insiders	34,003,932	12%
VC/PE Firms	35,607,903	12.6%
Institutions	196,783,943	69.6%

Dilution of Shares: Shareholders have been substantially diluted in the past year, with total shares outstanding growing by 87.8%.

Top Shareholders

Top 25 shareholders own 81.56% of the company

Ownership	Name	Shares	Current Value	Change %	Portfolio %
11.4%	Jonathan Lim	32,355,576	US$87.4m	0%	no data
6.86%	Frazier Life Sciences Management, LP	19,391,687	US$52.4m	19.6%	2.07%
5.97%	T. Rowe Price Group, Inc.	16,889,994	US$45.6m	128%	no data
5.74%	VR Adviser, LLC	16,216,216	US$43.8m	0%	2.06%
5.43%	BlackRock, Inc.	15,356,680	US$41.5m	44.7%	no data
4.87%	Suvretta Capital Management, LLC	13,768,039	US$37.2m	0%	1.33%
4.7%	The Vanguard Group, Inc.	13,288,740	US$35.9m	28.4%	no data
3.91%	Arch Venture Partners, L.P.	11,055,554	US$29.8m	0%	3.0%
3.86%	Logos Global Management, L.P.	10,900,000	US$29.4m	84.8%	3.42%
3.77%	Paradigm Biocapital Advisors LP	10,668,141	US$28.8m	47.2%	0.99%
3.13%	Artal Group S.A.	8,857,179	US$23.9m	-8.03%	0.62%
2.46%	Silverarc Capital Management, LLC	6,946,488	US$18.8m	-11.1%	4.29%
2.39%	Vivo Capital, LLC	6,756,756	US$18.2m	0%	1.44%
2.13%	State Street Global Advisors, Inc.	6,027,620	US$16.3m	145%	no data
1.91%	5AM Venture Management, LLC	5,405,404	US$14.6m	0%	2.96%
1.72%	PFM Health Sciences, LP	4,876,911	US$13.2m	4.39%	0.83%
1.59%	Geode Capital Management, LLC	4,502,698	US$12.2m	36%	no data
1.53%	Citadel Advisors LLC	4,315,673	US$11.7m	31%	0.01%
1.46%	Woodline Partners LP	4,138,849	US$11.2m	0.12%	0.09%
1.45%	Janus Henderson Group plc	4,109,548	US$11.1m	-49.8%	no data
1.18%	Bank of America Corporation, Asset Management Arm	3,324,433	US$9.0m	264%	no data
1.07%	Goldman Sachs Group, Investment Banking and Securities Investments	3,037,592	US$8.2m	60.6%	no data
1.07%	Marshall Wace LLP	3,027,727	US$8.2m	-17.6%	0.01%
1.01%	Andreessen Horowitz LLC	2,862,500	US$7.7m	0%	0.09%
0.88%	Affinity Asset Advisors, LLC	2,499,431	US$6.7m	0%	1.14%